text.skipToContent text.skipToNavigation
Need help? Please contact us

The Importance of Toxicology Studies in Drug Development

A substantial level of attrition for drug candidates is generally due to various toxicities and leads to high development costs, especially when not recognized until late in clinical trials. There is a great need for more useful biomarkers and short-term predictive assays for use in early drug discovery and development. 

Understanding the absorption, distribution, metabolism, excretion (ADME), and toxicity (ADME-Tox) of new drugs is a key element of drug discovery. These studies provide insights into the disposition of a pharmaceutical compound in the body, including its safety and efficacy.

View ADME-Tox portfolio

One of the key challenges with interpretation of toxicity studies in pre-clinical drug development is identifying the appropriate models that can provide clinically relevant results. While animal models remain one of the most important tools in preclinical toxicity studies, in vitro systems such as culturing primary human cells are becoming increasingly important for decision making in the drug development pipeline.

As a solution partner in toxicology, Lonza has robust portfolios in hepatoxicity, nephrotoxicity, respiratory toxicity, dermal toxicity and neurotoxicity.    

Lonza toxicology products

Pharmacokinetics and bioactivation



Absorption Modeling



 

Mechanistic Toxicity